A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer

NCT06202248 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-metastatic Prostate Cancer
Locally Recurrent Prostate Cancer

Interventions

DEVICE: Experimental: DaRT seeds

Sponsor

Alpha Tau Medical LTD.